PARRISH STEPHEN R 4
4 · NPS PHARMACEUTICALS INC · Filed Jan 12, 2004
Insider Transaction Report
Form 4
PARRISH STEPHEN R
VP, Manufacturing
Transactions
- Sale
Common Stock
2004-01-09$34.95/sh−800$27,960→ 0 total - Exercise/Conversion
Common Stock
2004-01-09$17.83/sh+800$14,264→ 800 total - Exercise/Conversion
Stock Option
2004-01-09$17.83/sh−800$14,264→ 26,400 totalExercise: $17.83From: 2003-09-20Exp: 2012-09-20→ Common Stock (800 underlying)
Footnotes (1)
- [F1]This transaction was executed under a Rule 10b5-1 trading plan.